Order

Size
Price
Stock
Qty

SCIO 469

 - Talmapimod
Axon 1671
CAS:  309913-83-5
Purity:  98%
  • Soluble in DMSO
  • MF:  C27H30ClFN4O3
  • MW:  513

Description

SCIO 469 is an orally available and selective p38α MAP kinase inhibitor with approximately 10-fold selectivity over p38β and strong selectivity versus a broad kinase panel.

p38 MAPK signaling regulates inflammatory cytokine production, stress responses and tumor microenvironment biology. SCIO 469 is useful for dissecting p38α-dependent inflammatory and antineoplastic pathways.

Key Features

  • Selective p38α MAPK inhibitor
  • Approximately 10-fold selective for p38α over p38β
  • Highly selective versus a broad kinase panel
  • Relevant to inflammatory and cancer signaling models

Applications

  • p38 MAPK pathway research
  • Cytokine and inflammatory signaling assays
  • Stress-response kinase studies
  • Immunomodulatory and oncology pharmacology

Related Products

AXON ID NAME FROM PRICE
1122 SL 327

From $88.00

1223 PD98059

From $88.00

1357 SD 169

From $66.00

1358 BIRB 796

From $71.50

1363 SB 203580

From $104.50

1364 SB 202190

From $104.50

1365 PD169316

From $104.50

1368 PD184352

From $88.00

1408 PD0325901

From $55.00

1465 SB 203580 hydrochloride

From $77.00

1516 AZD6244

From $66.00

1621 XMD 8-92 trifluoroacetate

From $77.00

1694 FR 180204

From $104.50

1761 GSK 1120212

From $77.00

1809 BIX 02189

From $121.00

1811 VX 745

From $99.00

1837 PH 797804

From $126.50

1846 XMD 8-92

From $77.00

1895 LY 2228820

From $115.50

1999 AZD8330

From $115.50

2318 FC 99 hydrochloride

From $104.50

2366 NG 25 trihydrochloride

From $82.50

2444 SB 706504

From $137.50

2520 U 0126

From $99.00

Loading...